Durect Corp
NASDAQ:DRRX
| Market Cap (Intraday) | 408.30M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.79 |
| 50-Day MA | $1.96 |
| 200-Day MA | $2.01 |
Durect Corp Stock, NASDAQ:DRRX
10260 Bubb Road, Cupertino, California 95014-4166
United States of America
Phone: +1.408.777.1417
Number of Employees: 81
Description
DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.